lilly's glp 1 Lilly Molecular Glue Administration Anounces Landmark GLP-1 Pricing

doi: 10.1016/S0140-6736(23)01200-X

PMID: 30145136

Samimi and colleagues found that LC supplementation (250 mg per day orally for 12 weeks) lead to significant reduction in body weight, BMI, waist and hip circumference respectively as well as improved glycemic control in women with PCOS (mean age 24.8 5.5 years) [12]

In contrast, modern GLP-1 receptor agonists and dual incretin agonists have demonstrated clinically meaningful and sustained reductions in body weight, with additional benefits on glycemic control and cardiometabolic risk markers

AOD-9604 is only a fragment of the growth hormone molecule, specifically the region associated with fat metabolism